http://www.fpnotebook.com/
Gestational Diabetes Management
Aka: Gestational Diabetes Management
- Indications: Gestational Diabetes
- Abnormal Glucose Tolerance Test 3 hour
- Preexisting Diabetes Mellitus
- Monitoring: Blood Glucose
- Frequency of Blood Glucose Monitoring
- Insulin therapy: qid Blood Sugar Monitoring
- Diet control: 4 Blood Sugars on 2 days per week
- Increase monitoring if 2 values/week abnormal
- Target Levels
- Before Breakfast or early morning (2-6 am): 60 to 96 mg/dl
- Before Lunch,Dinner: 60 to 115 mg/dl
- One hour post prandial goal: under 140 mg/dl
- Two hour post prandial goal: under 120 mg/dl
- Check Urine Ketones in early morning
- Preferred monitoring: Postprandial Blood Glucose
- Post-prandial Blood Glucose Monitoring preferred
- Associated with improved outcomes
- Lower Hemoglobin A1C levels
- Lower birth weights
- Fewer cesarean sections
- References
- De Veciana (1995) N Engl J Med 333:1237-41
- Evaluation: Initial
- Diabetic diet
- Diabetic nurse consultation
- Initiate home Blood Sugar Monitoring
- See Blood Glucose Monitoring above
- Management: Diet controlled management
- Indications
- Blood Sugars within target range (see above)
- Monitoring
- See Blood Glucose Monitoring above
- Dietary recommendations
- Restrict carbohydrates to <40% of daily calories
- Caloric restriction if BMI > 30 kg/m2
- Limit to 25 KCal/kg of actual weight per day
- Avoid severe caloric restriction
- Ketonemia associated with psychomotor delay
- Rizzo (1995) Am J Obstet Gynecol 173:1753-8
- Exercise recommendations
- Regular aerobic Exercise improves glycemic control
- Circuit Resistance Training improves glycemic control
- Brankston (2004) Am J Obstet 190:188-93
- Management: Insulin
- Indications
- Failed diet control (see above)
- Fasting Blood Glucose > 95 mg/dl or
- Two hour postprandial Blood Glucose >120 mg/dl
- Preexisting Insulin Dependent Diabetes Mellitus
- Protocol
- See Insulin Management in Pregnancy
- Endocrine consult as needed for Insulin Dosing
- Protocols: Experimental (not to be used in practice)
- Glyburide is only hypoglycemic not contraindicated
- ACOG and ADA do not recommend use until further RCT
- Unclear whether Glyburide crosses the placenta
- Jacobson (2005) Am J Obstet Gynecol 193(1): 118-24
- Glucophage is also being studied in pregnancy
- Rowan (2008) N Engl J Med 358(19):2003-15
- Glueck (2002) Hum Reprod 17:2858-64
- Pregnancy in Metabolic Syndrome on Metformin: 42%
- If occurs on Metformin, continue for first 20 weeks
- Prevents Rebound Hyperglycemia
- Second Generation Sulfonylureas experimentally used
- Blood Sugar controlled as well as Insulin
- Markedly reduced Hypoglycemia with Oral Hypoglycemic
- No increased fetal anomaly or perinatal death
- References
- Greene (2000) N Engl J Med 343:1178-9
- Langer (2000) N Engl J Med 343:1134-8
- Monitoring: Antepartum aggressive monitoring for complications
- Monitoring starting at 32 weeks gestation
- Weekly Non-Stress Test (biweekly if on Insulin or poor control)
- Amniotic fluid weekly if on Insulin or poor control
- Some protocols include Biophysical Profile
- Daily Fetal Kick Counts starting at 34 weeks gestation
- Obstetric Ultrasound monthly
- Assess Fetal Growth
- Prenatal Visit frequency and monitoring based on Blood Sugar control
- Plan Labor Induction by 39-40 weeks
- Management: Intrapartum
- See Insulin Management in Labor
- Timing of delivery
- Consider offering Cesarean section for EFW > 4500 g
- Delivery prior to 40 weeks not indicated unless
- Poor glycemic control
- Other fetal or maternal complications
- Management: Postpartum Care
- Consider Glucose Tolerance Test 2 hour (75 g Glucola)
- Non-Lactating: Schedule at 6 weeks to 3 months
- Breast Feeding: Schedule at 6 months
- Maintain ideal body weight
- Moderate intensity Exercise for 150 minutes per week
- Fasting Blood Glucose yearly
- Risk of developing Type II Diabetes Mellitus within 10 years: 50%
- References
- Serlin (2009) Am Fam Physician 80(1):57-62
- Turok (2003) Am Fam Physician 68(9):1767-72